Details

Hepatic management of toxic sterols after acute deletion of Cyp51 from cholesterol synthesis
ID Kreft, Tinkara (Author), ID Blagotinšek Cokan, Kaja (Author), ID Skubic, Cene (Author), ID Režen, Tadeja (Author), ID Perše, Martina (Author), ID Wechtersbach, Karmen (Author), ID Kojc, Nika (Author), ID Jeruc, Jera (Author), ID Debeljak, Željko (Author), ID Heffer, Marija (Author), ID Matz-Soja, Madlen (Author), ID Rozman, Damjana (Author)

.pdfPDF - Presentation file, Download (21,88 MB)
MD5: BE0FCECBD8546ED8D352D67B2A3488C8
URLURL - Source URL, Visit https://www.jbc.org/article/S0021-9258(26)00058-X/fulltext This link opens in a new window

Abstract
Lanosterol 14α-demethylase (CYP51), a key enzyme in cholesterol synthesis, is essential for normal liver function. Reduced CYP51 activity leads to metabolism-associated liver disease and ultimately hepatocellular carcinoma, yet the hepatocellular processes most affected and their crosstalk with other liver cell types remain poorly defined. Here, we present a new inducible, liver-specific Cyp51 knockout mouse model (iLKO) designed to study how acute disruption of cholesterol synthesis is managed in the adult liver. Doxycycline-inducible deletion minimizes developmental confounders of albumin-Cre models and enables isolation of viable primary hepatocytes. iLKO hepatocytes and liver tissue showed efficient CYP51 depletion with marked accumulation of lanosterol and 24,25-dihydrolanosterol, while hepatic cholesterol levels remained unchanged or only mildly reduced, indicating compensatory uptake and/or pathway rerouting. Histology and transmission electron microscopy (TEM) revealed hepatomegaly with mild portal inflammation, ductular reaction, endoplasmic reticulum (ER) dilation, mitochondrial swelling, and increased nuclear lipid droplets, consistent with adaptation to ER stress but without overt fibrosis at the studied time points. Notably, crystal-like inclusions - particularly in Kupffer cells - were observed. Although MALDI-TOF MS imaging could not determine their exact composition, their presence in the context of toxic sterol overload strongly suggests non-cholesterol sterol crystallization as a previously unrecognized trigger of inflammation. In summary, the iLKO model allows dissection of sterol toxicity independently of developmental effects and provides mechanistic insight into how disrupted cholesterol synthesis in adult hepatocytes initiates sterol-driven cellular stress and inflammation that predispose to metabolism-associated liver disease and hepatocellular carcinoma.

Language:English
Keywords:CYP51, cholesterol metabolism, crystals, cytochrome P450, lanosterol 14α-demethylase, lipid droplets, liver, mouse model, sterol
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2026
Number of pages:17 str.
Numbering:Vol. 302, iss. 3, art. 111188
PID:20.500.12556/RUL-179501 This link opens in a new window
UDC:577.2
ISSN on article:1083-351X
DOI:10.1016/j.jbc.2026.111188 This link opens in a new window
COBISS.SI-ID:267520771 This link opens in a new window
Publication date in RUL:16.02.2026
Views:223
Downloads:83
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Journal of biological chemistry
Shortened title:J. biol. chem.
Publisher:American Society for Biochemistry and Molecular Biology
ISSN:1083-351X
COBISS.SI-ID:19301415 This link opens in a new window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.

Secondary language

Language:Slovenian
Keywords:CYP51, presnova holesterola, kristali, citokrom P450, lanosterol 14α-demetilaza, lipidne kapljice, jetra, mišji model, sterol

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0390
Name:Funkcijska genomika in biotehnologija za zdravje

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J1-9176
Name:HolesteROR pri presnovnih boleznih jeter

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J1-50024
Name:Povezava med hipoksijo in sintezo holesterola v cirkadianem času

Funder:ARIS - Slovenian Research and Innovation Agency
Funding programme:ESFRI-ELIXIR

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:BI-DE/17-19-8

Funder:ARIS - Slovenian Research and Innovation Agency
Name:Young researchers

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:I0-0022
Name:Mreža raziskovalnih infrastrukturnih centrov Univerze v Ljubljani (MRIC UL)

Funder:BMBF - Germany, Federal Ministry of Education and Research
Project number:031L0053
Name:Liver Systems Medicine
Acronym:LiSyM

Funder:BMBF - Germany, Federal Ministry of Education and Research
Project number:031L0256C
Name:Liver Systems Medicine Against Cancer
Acronym:LiSyM Cancer

Funder:BMBF - Germany, Federal Ministry of Education and Research
Project number:031L0258E
Name:Liver Systems Medicine Against Cancer
Acronym:LiSyM Cancer

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back